GlassScriptPhysician profile
Mary B Lesh
NPI 1417983834
$20,968.31
in general payments reported to CMS, 2019-2025
6 companies · $4,384 in 2025
The $4,384 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,933 · 2022: $4,873 · 2023: $3,808 · 2024: $4,969 · 2025: $4,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,214 · Travel and Lodging: $2,745 · Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,214.00 |
| Travel and Lodging | $2,744.52 |
| Food and Beverage | $1,202.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14,962.44 | 2021-2025 | Hemlibra |
| Genzyme Corporation | $4,817.60 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $705.08 | 2022-2023 | |
| Genentech, INC. | $320.96 | 2024-2025 | Hemlibra |
| Pfizer INC. | $90.23 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Lesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.